We showed that treatment with low concentrations of the USP7 inhibitor selectively induces apoptosis of MEC-1 and EHEB CLL cell lines and primary CLL CD19+ lymphocytes, while maintaining unaffected CD19+ lymphocytes from normal individuals. The gene discussed is USP7; the disease is B-cell chronic lymphocytic leukemia.